Raj Bakhru, CFA, CISSP
FounderFounder at Blueflame AI
New York, New York, United States
FoundedBlueflame AI
About
Raj Bakhru is the Founder, Chairman, Chief Executive Officer, and Chief Business Officer of Cadrenal Therapeutics, Inc. (Nasdaq: CVKD), a biopharmaceutical company he led from formation through its Nasdaq IPO and the acquisition of its lead compound, CAD-1005. The company's pipeline includes CAD-1005, an IV 12-LOX inhibitor for Heparin-Induced Thrombocytopenia and Cardiac Surgery Associated-Acute Kidney Injury, and Tecarfarin, an oral vitamin K antagonist. Bakhru holds the CFA and CISSP designations, is a former U.S. Marine aviator, and has been recognized as an EY Entrepreneur of the Year and BioFlorida Executive of the Year.
Founder at Blueflame AI
Co-founders at Blueflame AI
RB
Raj BakhruManaging Member
Experience
- DatasiteGeneral Manager, Blueflame AI / Data & Intelligencecurrent2025 — presentNew York, New York, United States
- BlueFlame AIChief Executive Officer2023 — 2025New York, NY
- ACA GroupSenior Adviser2023 — 2024
- ACA GroupChief Strategy Officer2022 — 2023New York, United States
- ACA GroupChief Innovation Officer - Head of RegTech, ESG, Strategy, and M&A2019 — 2022
- ACA GroupPartner, Division Head - Cybersecurity and Risk at ACA Aponix2015 — 2019NY, NY
- Aponix Financial TechnologistsFounder & CEO2014 — 2015White Plains, NY
- Kepos Capital, L.P.Technology2010 — 2014NY, NY
- Highbridge Capital ManagementVice President2008 — 2010
- Goldman Sachs Asset ManagementApplication Developer2005 — 2008
Skills & more
Trading Systems28Bloomberg5Sybase1Derivatives15Electronic Trading11Quantitative Finance15Hedge Funds24Fixed Income10Market Data4Options11Equities16Credit Derivatives2
+10 more
Asset ManagementEquity DerivativesFX OptionsCybersecurityCloud SecurityPrivate EquityDue DiligenceFinancial ServicesIT RiskPrivacy- Amazon Web Services Solutions Architect Associate — Amazon Web Services (AWS)
- CISSP — ISC(2)
- Chartered Financial Analyst (CFA) — CFA Institute
From Raj's professional profile.
Frequently asked questions
- Who is Raj Bakhru, CFA, CISSP?
- Raj Bakhru is the Founder, Chairman, Chief Executive Officer, and Chief Business Officer of Cadrenal Therapeutics, Inc. (Nasdaq: CVKD), a biopharmaceutical company he led from formation through its Nasdaq IPO and the acquisition of its lead compound, CAD-1005. The company's pipeline includes CAD-1005, an IV 12-LOX inhibitor for Heparin-Induced Thrombocytopenia and Cardiac Surgery Associated-Acute Kidney Injury, and Tecarfarin, an oral vitamin K antagonist. Bakhru holds the CFA and CISSP designations, is a former U.S. Marine aviator, and has been recognized as an EY Entrepreneur of the Year and BioFlorida Executive of the Year.
- Where does Raj Bakhru, CFA, CISSP work?
- Raj Bakhru, CFA, CISSP is Founder of Blueflame AI.
- What companies did Raj Bakhru, CFA, CISSP found?
- Raj Bakhru, CFA, CISSP founded Blueflame AI.
- Where did Raj Bakhru, CFA, CISSP go to school?
- Raj Bakhru, CFA, CISSP studied at Columbia University (BS, Computer Engineering).
Same school
Also attended Columbia University726
Ben HorowitzCo-founder & General Partner at Andreessen HorowitzDoug LeonePartner at Sequoia Capital; former Global Managing PartnerChris DixonFounder & Managing Partner of a16z crypto at Andreessen HorowitzKai-Fu LeeChairman of Sinovation Ventures and CEO of 01.AIGabriella GiglioHR & Executive Talent at General CatalystScott BillerInvestor at GV (Google Ventures)
+ 720 more
Shared employers
Also worked at ACA Group3
Also worked at Highbridge Capital Management5
Also worked at Goldman Sachs Asset Management1,505
Josh KushnerFounder & CEO of Thrive CapitalSarah GuoFounder & General Partner of ConvictionFred EhrsamCo-founder and Senior Advisor at Paradigm; founder of NudgeMatt HuangCo-founder and Managing Partner at ParadigmDavid VélezFounder & CEO of NubankTarek MansourCo-founder & CEO of Kalshi
+ 1,499 more